22 May 2025
22 May 2025
Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.
Featuring an 88-element phased linear array, the catheter claims to deliver detailed visualisation.
The randomised, controlled trial assessed the system's safety and efficacy.
Biolife's haemostatic devices are manufactured under the StatSeal and WoundSeal brand names.
The trial will be carried out at various orthopaedic centres in the US and Europe, focusing on the device’s safety.
ClearFlow’s PleuraFlow Active Clearance Technology demonstrated a 64% reduction in ICU readmissions.
Available in the US since 2021, Philips’ VeriSight Pro 3D ICE catheter provides 2D and 3D imaging in real time.
The PHASIFY technology facilitates at-home sample collection, promoting preventive care and proactive health management.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
